Shreya Biotech

Shreya Biotech is the specialized biotechnology division of Shreya Life Sciences, a prominent Indian pharmaceutical group. The company focuses on the development, manufacturing, and commercialization of high-quality biopharmaceuticals, most notably recombinant human insulin (marketed as Recosulin) and vaccines such as the Hepatitis B vaccine (Shrevac-B). Operating out of state-of-the-art WHO-GMP certified facilities in Aurangabad and Roorkee, Shreya Biotech leverages advanced recombinant DNA technology and large-scale fermentation processes. The company maintains a strong international presence, particularly in Russia, the CIS region, and Africa, while also serving as a strategic CDMO partner for global pharmaceutical firms. Their portfolio extends across therapeutic areas including endocrinology, infectious diseases, and ophthalmology.